Clinical Trial Update: Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial called CAPTAIN-T2D by Sparrow Pharmaceuticals is currently recruiting for patients with type 2 diabetes and cortisol excess.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Sparrow Pharmaceuticals | Conditions: Type 2 Diabetes, Cortisol Excess | Phase 2 | Status: RECRUITING